Objectives: To define appropriate antibiotic use in hospitalized adults treated for a bacterial infection, we previously developed and validated a set of six generic quality indicators (QIs) covering all steps in the process of antibiotic use. We assessed the association between appropriate antibiotic use, defined by these QIs, and length of hospital stay (LOS).
Introduction
There is an increasing interest in appropriate antibiotic usage and, more importantly, how we can improve it in daily clinical care. [1] [2] [3] A growing body of evidence illustrates that antibiotic stewardship programmes (ASPs) can both optimize treatment of infections and reduce antibiotic resistance. 4, 5 In most of these studies guideline-concordant empirical therapy was used to define appropriate antibiotic use. 6, 7 However, appropriate antibiotic use requires more than appropriate empirical therapy alone.
In earlier studies we developed and validated a comprehensive set of quality indicators (QIs) to define appropriate antibiotic use in patients with urinary tract infections (UTIs). 8 For patients with complicated UTIs, appropriate antibiotic use, defined by this comprehensive set of UTI-specific QIs, reduced length of hospital stay (LOS). 9 LOS is a relevant outcome measure because it reflects the recovery time of patients and defines hospital costs. 10 To be able to evaluate the quality of antibiotic use covering all steps in the process of antibiotic treatment and in all hospitalized adult patients with a suspected bacterial infection, we developed a set of 11 generic QIs. 11 In a recent systematic review regarding the current evidence on the effects of using these generic QIs on patients' clinical outcome, costs and bacterial resistance, 12 seven QIs indeed showed beneficial effects on outcome, although the quality of evidence was generally low and heterogeneity between studies mostly moderate to high. 12 The set of QIs was also tested in daily hospital practice and six process QIs, which measured various steps in the process of antibiotic use at patient level, turned out to have sound clinimetric properties. 13 These QIs were:
prescribe empirical treatment in accordance with the guideline; take two sets of blood cultures before start of treatment; take a culture from the suspected site of infection; document an antibiotic plan in the case notes; switch from intravenous (iv) to oral therapy within 72 h; and tailor antibiotic treatment to pathogendirected therapy on the basis of the culture results.
The aim of the current study was to evaluate, in 1890 hospitalized adult patients with a broad range of (suspected) bacterial infections, the association between appropriate antibiotic use, as defined by these generic QIs, and LOS. Secondary outcomes were in-hospital mortality, ICU admission during hospital stay and readmission within 30 days.
Patients and methods

Setting, study population and data collection
We conducted an observational multicentre study in 4 university and 18 (medium-sized and small) non-university hospitals. We prospectively identified in each hospital, in a point prevalence measurement on non-ICU departments, all adult inpatients using antibiotics for >24 h for a suspected hospital-or community-acquired bacterial infection. This point prevalence measurement primarily aims to identify nosocomial infections, and is performed biannually by PREZIES (prevention of nosocomial infections by surveillance), a department of the Dutch National Institute for Public Health and the Environment (RIVM, The Netherlands).
14 Patients were included in October 2011, March 2012 and October 2012 and excluded if antibiotics were used as prophylaxis, or when started on the ICU or in another hospital (Figure 1 ). Clinical and laboratory data were extracted retrospectively from medical and nursing records and medication charts. Comorbidity was measured by means of the Charlson comorbidity index, 15 and severity of illness was defined as the MEWS (Modified Early Warning Score) at the start of treatment. 16 All data needed to compute the QIs or to assess potential confounders were extracted in a uniform way and entered in the database anonymously.
Ethics
The Medical Ethics Committee of the AMC (Academic Medical Center Amsterdam) assessed the study and concluded that it was deemed exempt from their approval.
QIs and definitions
The development of the QIs has been described earlier. 11 The final set of six validated generic QIs defining appropriate antibiotic use and covering various steps in the process at the patient level is described in detail in Table  1 . 13 For some of the QIs, we had to develop the following extensive working definitions and algorithms to compute appropriateness scores.
QI 1: Prescribe empirical antibiotic therapy according to the national guideline
We defined empirical therapy as the antibiotic or antibiotic combination prescribed on the day of diagnosis, before identification of a causative pathogen. If initial therapy was directed at a previously cultured pathogen, this was not called 'empirical therapy' and these patients were excluded for this indicator. We used the Dutch national guidelines current at that moment (http://www.swab.nl/guidelines and www.swabid.nl) to evaluate whether the prescribed empirical regimen (antibiotic or antibiotic combination) was in accordance with the guideline. Individual patient characteristics, in particular allergies, pregnancy and previous ESBL infection, were taken into account when computing the algorithms for appropriate empirical therapy. Only patients with one or two (possible) diagnoses covered by a guideline were included. Patients with more than two (possible) infections or with a (possible) infection not covered by a guideline were excluded. In cases in which two diagnosed or possible infections affected a single organ system, it usually concerned a differential diagnosis, and antibiotic therapy was considered correct if covered by one of the two applicable guidelines. However, if one of these infections was clearly more severe than the other (e.g. pyelonephritis versus cystitis), antibiotic therapy was only considered correct if covered by the guideline for the more severe infection. If the two (possible) infections affected different organ systems [e.g. lower respiratory tract infection (RTI) and UTI], antibiotic therapy was only considered correct if both diagnoses were covered according to their respective guidelines.
QI 5: Antibiotic therapy should be switched from intravenous to oral therapy within 48-72 h This QI was applicable to the subgroup of patients who started with iv antibiotic treatment and fulfilled the criteria for safe early switch (Figure 2 Appropriate inpatient antibiotic use JAC pathogen-directed antibiotic treatment after culture results became positive. We estimated conservatively that in general culture results are available at day 5. Therefore, the antibiotic (combination) given at day 5 was considered the final therapy. This therapy was considered pathogendirected when it was in accordance with the resistance pattern of the cultured microorganism, regardless of whether antibiotic therapy was changed. Where possible according to the culture results, antibiotics should be chosen from the recommended group of antibiotics ('narrower-spectrum') ( Figure 3 ).
1
QI sum score
This sum score was defined as the overall performance on all QIs (appropriate ¼ 1; inappropriate ¼ 0) for a patient divided by the number of QIs that applied to that specific patient. For example, iv-oral switch was not possible in all patients. As QI 2, taking blood cultures, and QI.4, documenting the antibiotic plan, applied to all patients, the minimum number of applicable QIs was two and the maximum number six. We divided the sum scores into two groups: low sum scores (0%-49%) versus high scores (50%-100%).
Definitions LOS in community-acquired infections was defined as the number of days between admission and discharge. Hospital-acquired infections were defined by the start of antibiotic treatment because of a suspected infection at least 48 h after admission. In these patients LOS was defined as the number of days between start of antibiotic treatment and discharge. Readmission was defined as an admission within 30 days after discharge, with the primary diagnosis being an infection in the same organ system as before discharge.
Analysis
Collected data were entered in a database using the Statistical Package for the Social Sciences (SPSS 20Á0 for Windows V R , SPSS Inc., Chicago, IL, USA). Algorithms were created in SPSS for every QI to determine whether a patient met the criteria for the denominator and numerator.
To investigate the relationships between LOS and performance on the single QIs and overall performance on the set of QIs (i.e. the sum score), we used multilevel (linear mixed model) analyses, because of the hierarchical structure of this study (patients nested within hospitals). We used a model with random intercept and all other variables fixed. We adjusted for the quantity of QIs in the sum score and conducted sub-analyses for patients with community-acquired versus hospital-acquired infections. LOS was log-transformed before analyses were done to satisfy normality assumptions, and LOS was back-transformed for presentation as geometric mean (95% CI), and the estimated difference was given as a percentage. 18 Secondary outcomes (in-hospital mortality, ICU admission and readmission within 30 days) were also analysed using multilevel (linear mixed model) analyses.
The following variables were included as potential confounders for the relationship between QI scores and outcome: sex; age; community versus hospital-acquired infections; type of diagnosis [divided into seven groups: UTI; RTI; skin and soft tissue infection; intra-abdominal infection; other infection; two possible diagnoses at start of antibiotic treatment; and more than two possible diagnoses/diagnosis not covered by the guideline]; severity of illness (MEWS); comorbidity (Charlson comorbidity index); prior use of antibiotics (last 30 days before start of treatment); start of antibiotics iv or orally; and type of hospital [university hospital, medium-sized non-university hospital (!500 beds) or small non-university hospital (<500 beds)]. We tested with multivariate multilevel (linear mixed) analyses whether these variables had an effect (P < 0.10) on LOS. We computed the estimate of the total causal effect between QI outcome and LOS before and after adjusting for a significant variable. If the adjusted estimate varied by !10% compared with the unadjusted estimate, confounding was present and in that case we adjusted for this variable. A value of P < 0.05 was considered statistically significant.
Results
Study population
The patient population consisted of 1890 inpatients treated with antibiotics for a suspected bacterial infection ( Figure 1) ; 1391 (74%) of the infections were community acquired. The mean patient age was 69.8 years, 51.5% were male and 41% of patients fulfilled the sepsis criteria [!2 systemic inflammatory response syndrome (SIRS) criteria]. Twenty-six percent of patients had a MEWS !3. For further baseline characteristics, see Table 2 . Not every indicator applied to all included patients, so the sample size of the QIs varied (Tables 3 and 4 ). The percentages of appropriate antibiotic use as defined by the six QIs varied between 32 (iv-oral switch) and 61 (documenting the antibiotic plan).
QIs and LOS
The geometric mean for LOS was 10.2 (95% CI 3-42) days for community-acquired infections and 11.9 (95% CI 3-53) days for hospital-acquired infections. Variables with an effect on LOS were community-versus hospital-acquired infections, type of diagnosis, comorbidity (Charlson comorbidity index), severity of illness (MEWS), prior use of antibiotics (last 30 days before start of treatment), starting antibiotics iv or orally, age and sex. In the subgroups not all variables had an effect on LOS (Table 5) .
Associations between appropriate antibiotic use (as described by the six QIs) and LOS are listed in Tables 3 and 4 . A significant association was demonstrated between an early iv-oral switch and a shorter LOS (6.5 versus 11.2 days; P < 0.001), and in both subgroups separately. Prescribing empirical therapy in accordance with the national guideline had a significant association with a shorter LOS in the subgroup of community-acquired infections (8.8 versus 10.5 days, P ¼ 0.009). Streamlining empirical therapy, performing blood cultures or a culture from the suspected site of infection and documenting an antibiotic plan were not significantly associated with LOS.
Performance on the total set of QIs and LOS
In many patients only two, three, four or five QIs applied; the QI regarding iv-oral switch involved only 22% of the patients and van den Bosch et al. In three patients it was unknown whether antibiotics were started empirically or based on culture. In two patients it was unknown whether antibiotics were started iv or orally.
Appropriate inpatient antibiotic use JAC streamlining antibiotic therapy 21% of the patients. The proportion of appropriate use in each patient was associated with LOS: 10.1 days for patients with a high sum score versus 11.2 days for those with a low score (P ¼ 0.002). This also applied to the subgroup with community-acquired infections (9.7 versus 10.9 days; P ¼ 0.007). The subgroup with hospital-acquired infections (11.6 versus 12.2 days; P ¼ 0.08) was smaller, and although patients with a high sum score had a shorter LOS, the difference was not significant (Tables 3 and 4) .
QIs and secondary outcomes
Appropriate antibiotic use as defined by the six QIs was not significantly associated with lower in-hospital mortality (Tables S1-S3,  available as Supplementary data at JAC Online), ICU admissions (Tables S4-S6 ) or readmission within 30 days after discharge (Tables S7-S9 ).
Discussion
In a cohort of 1890 hospitalized patients treated with antibiotics for a suspected bacterial infection, an early iv-oral switch is associated with a reduction of 4 days in LOS and a higher proportion of appropriate antibiotic use (defined by the performance on the total set of QIs) appears to be associated with a reduction of 1 day in LOS. We found no association between performance on QIs and in-hospital mortality, ICU admission or readmission rate. In our recently published systematic review on antimicrobial stewardship objectives we expressed the need for more evidence regarding the effects of meeting stewardship objectives, and the combined effect of meeting several objectives. 12 To our knowledge, this study is the first to evaluate the relationship between appropriate antibiotic use, defined by a set of validated generic QIs, and LOS in hospitalized patients treated with antibiotics for a variety of suspected bacterial infections. Appropriate inpatient antibiotic use
JAC
The major strength of this study is the unselected and large patient population, from many different hospitals and departments. Our study population comprises the everyday clinical case mix of hospitalized patients. Since community-acquired and hospitalacquired infections define different patient groups, especially concerning LOS, we adjusted for this variable in all analyses, and also performed sub-analyses with only community-acquired infections. Another strength was the use of generic QIs, 11 which measure the various steps in the process of antibiotic use at patient level. After collection of the data, algorithms were created in SPSS to score the QIs, thereby excluding personal interpretations or preferences. Finally, LOS is a continuous variable applicable to all patients and should in theory be sensitive to differences in quality of care, but LOS is subjected to numerous confounders. 19 We therefore controlled for potential confounders that might have an impact on LOS, and since outliers in LOS are common, LOS was log-transformed before analyses were done to satisfy normality assumptions. Adjusting for confounders did not alter our conclusions.
Our study has some limitations. The design is observational and, although we controlled for known confounders, 6, 19 we might not have controlled for all variables associated with LOS. Next, data were collected retrospectively, and it is not possible to collect all clinically relevant data. Regarding the iv-oral switch QI, we therefore had to assume clinical stability at 48-72 h of antibiotic treatment if not stated otherwise in the medical records, and when temperature or blood pressure was not mentioned in the medical records we likewise assumed that abnormal values would have been registered. Further, not all data that affected the physicians' choices may have been documented properly, which may lead to wrong conclusions when classifying antibiotic use as appropriate or inappropriate. However, we constructed the QIs to be based on objective, retrievable data as much as possible. Finally, dosing of antibiotics was not evaluated, and selection of appropriate but under-dosed antibiotics may still lead to clinical failure and longer LOS.
An early iv-oral switch has been shown to be safe and is associated with significantly reduced LOS. 9, 12, 20 Our study and previous studies point out that it is still not routine clinical care.
9,20 Even after 5 days only 57% of the patients who met the safe switch criteria within 72 h were switched to oral antibiotics, with a wide range between hospitals. An early switch was the only single QI associated with a shorter LOS, but this does not explain the association between the sum score and LOS, as the QI regarding iv-oral switch applied to only 22% of patients.
We only found an association between empirical antibiotic treatment according to (national) guidelines and LOS in patients with community-acquired infections, in accordance with previous studies. 6, 12, 21 However, there are also studies that did not find such an association. 9, 19 Appropriate empirical therapy is effective van den Bosch et al.
for increasing coverage rates without prescribing unnecessarily broad regimens, 3 but if inappropriate empirical treatment is unnecessarily broad, this may not have a direct negative effect on LOS. Another explanation why guideline-adherent empirical therapy does not affect LOS might be that in patients with lower severity of illness adequate antibiotic therapy may be less crucial for clinical outcomes. 22 In our patient sample only 40% met the criteria for sepsis (SIRS criteria). 23 No associations were found between LOS and performing blood cultures or a culture from the suspected site of infection, streamlining of antibiotic therapy or documenting an antibiotic plan. It appears that influencing LOS by performing appropriate microbiological investigations is difficult, since only a few studies found a positive effect on clinical outcome. 24, 25 However, microbiological investigations not only allow iv-oral switching, but also switching of empirical to pathogen-directed (streamlined) therapy, [26] [27] [28] which has been associated with a reduction in antibiotic use and costs. 12, 26, 29 More research is needed to evaluate the usefulness of streamlining in terms of patient outcome. 12, 30, 31 Documenting an antibiotic plan in case notes, while potentially contributing to appropriate antibiotic use, 32 was not associated with LOS, in accordance with previous studies. 12, 32, 33 The most important outcome of this study was that adherence to a combination of concomitant processes of care, but not adherence to one single QI, resulted in a decreased duration of hospital stay. It has been demonstrated before that, in particular, adherence to bundles of care improves patient outcome and might be a surrogate marker for a better global quality of care. 9, 23, 34, 35 In conclusion, we found that appropriate antibiotic use, as defined by the performance on the total set of QIs, in hospitalized adult patients with a suspected community-acquired infection appears to be associated with a shorter LOS. Illustrating links between processes of antibiotic care and outcome is essential to convince clinicians of the importance of appropriate prescribing of antibiotics and compliance with antibiotic stewardship programmes. 12 In addition, initiating stewardship activities that aim to improve compliance with these stewardship QIs might be an effective means to promote such appropriate care.
